Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.72 |
| ▸ | HPGD | P15428 | 7/20 | 0.72 |
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | TP53 | P04637 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22113685 | 0.88 | KDM4E (0.58) | ALDH1A1KDM4EHPGDMAPTLMNA | |
| SCHEMBL12070880 | 0.86 | KDM4E (0.67) | ALDH1A1KDM4EHPGDMAPTLMNA | |
| SCHEMBL14825461 | 0.86 | KDM4E (0.67) | ALDH1A1KDM4EHPGDMAPTLMNA | |
| SCHEMBL12072917 | 0.86 | ALDH1A1 (0.55) | ALDH1A1KDM4EHPGDMAPTLMNA | |
| SCHEMBL12072317 | 0.86 | ALDH1A1 (0.55) | ALDH1A1KDM4EHPGDMAPTLMNA | |
| SCHEMBL12072321 | 0.86 | ALDH1A1 (0.55) | ALDH1A1KDM4EHPGDMAPTLMNA | |
| SCHEMBL12072886 | 0.85 | KDM4E (0.65) | ALDH1A1KDM4EHPGDMAPTLMNA | |
| SCHEMBL12070870 | 0.85 | KDM4E (0.65) | ALDH1A1KDM4EHPGDMAPTLMNA | |
| SCHEMBL15829289 | 0.85 | ALDH1A1 (0.54) | ALDH1A1KDM4EHPGDMAPTLMNA | |
| SCHEMBL31658925 | 0.84 | ALDH1A1 (0.53) | ALDH1A1KDM4EHPGDMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11840538-B2 | Heterocyclic compounds and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-11050026-B2 | Spiro compound and organic light-emitting element comprising same | LG CHEM, LTD. | 2021-06-29 | — | — | US | disclosed |
| US-10734590-B2 | Heterocyclic compound and organic light-emitting element using same | LG CHEM, LTD. (KR) | 2020-08-04 | — | — | US | disclosed |
| US-20200190069-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2020-06-18 | — | — | US | disclosed |
| US-10577355-B2 | Hetero ring compound and organic luminescent element comprising same | LG CHEM, LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| US-10326082-B2 | Heterocyclic compound and organic light-emitting element using same | LG CHEM, LTD. (KR) | 2019-06-18 | — | — | US | disclosed |
| US-10263193-B2 | Heterocyclic compound and organic light-emitting element using same | LG CHEM, LTD. (KR) | 2019-04-16 | — | — | US | disclosed |
| US-10032997-B2 | Heterocyclic compound and organic light-emitting element using same | LG CHEM, LTD. (KR) | 2018-07-24 | — | — | US | disclosed |
| US-10032997-B2 | Heterocyclic compound and organic light-emitting element using same | LG CHEM, LTD. (KR) | 2018-07-24 | — | — | US | disclosed |
| US-20180175304-A1 | SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-06-21 | — | — | US | disclosed |
| US-9382253-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2016-07-05 | — | — | US | disclosed |
| US-9382253-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2016-07-05 | — | — | US | disclosed |
| US-9273080-B2 | Metal complexes | MEREK PATENT GMBH (DE) | 2016-03-01 | — | — | US | disclosed |
| US-9273080-B2 | Metal complexes | MEREK PATENT GMBH (DE) | 2016-03-01 | — | — | US | disclosed |
| US-20130112921-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2013-05-09 | — | — | US | disclosed |
| US-20130112921-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2013-05-09 | — | — | US | disclosed |
| US-20130082209-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2013-04-04 | — | — | US | disclosed |
| US-20130082209-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2013-04-04 | — | — | US | disclosed |
| WO-2012007087-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2012-01-19 | — | — | WO | disclosed |
| WO-2011157339-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2011-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10263193-B2 | Heterocyclic compound and organic light-emitting element using same | CRY1, NFE2L2, CRY2 | ALDH1A1 73/4885KDM4E 2254/4885HPGD 732/4885 |
| US-10326082-B2 | Heterocyclic compound and organic light-emitting element using same | CRY1, CRY2, NR2E3 | ALDH1A1 252/4885KDM4E 1127/4885HPGD 1235/4885 |
| US-10032997-B2 | Heterocyclic compound and organic light-emitting element using same | CRY1, CRY2, NR2E3 | ALDH1A1 252/4885KDM4E 1127/4885HPGD 1235/4885 |
| US-10734590-B2 | Heterocyclic compound and organic light-emitting element using same | CRY1, CRY2, NR2E3 | ALDH1A1 252/4885KDM4E 1127/4885HPGD 1235/4885 |
| US-20180175304-A1 | SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | NR2E3, CRY1, ERG | ALDH1A1 83/4885KDM4E 2931/4885HPGD 3365/4885 |
| US-11840538-B2 | Heterocyclic compounds and organic light emitting device using the same | CRY1, CYP1A1, CRY2 | ALDH1A1 16/4885KDM4E 3498/4885HPGD 485/4885 |
| US-10577355-B2 | Hetero ring compound and organic luminescent element comprising same | ORC3, CRY2, GLI1 | ALDH1A1 1942/4885KDM4E 1232/4885HPGD 4317/4885 |
| US-20130082209-A1 | METAL COMPLEXES | MCOLN2, MCOLN1, AP1M1 | ALDH1A1 2790/4885KDM4E 4129/4885HPGD 3092/4885 |
| US-11050026-B2 | Spiro compound and organic light-emitting element comprising same | NR2E3, CRY1, ERG | ALDH1A1 83/4885KDM4E 2931/4885HPGD 3365/4885 |
| US-20130112921-A1 | METAL COMPLEXES | MCOLN2, MCOLN1, NCLN | ALDH1A1 3236/4885KDM4E 3819/4885HPGD 3162/4885 |
| US-20200190069-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CRY1, CRY2, CYP1A1 | ALDH1A1 18/4885KDM4E 2374/4885HPGD 913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.